PRO-DEX INC (PDEX) Stock Price, Forecast & Analysis

NASDAQ:PDEX • US74265M2052

39.52 USD
+0.52 (+1.33%)
Last: Feb 20, 2026, 08:00 PM

PDEX Key Statistics, Chart & Performance

Key Statistics
Market Cap126.86M
Revenue(TTM)66.59M
Net Income(TTM)11.19M
Shares3.21M
Float2.03M
52 Week High70.26
52 Week Low23.47
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)3.24
PE12.2
Fwd PE16.28
Earnings (Next)04-29
IPO1994-05-31
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
PDEX short term performance overview.The bars show the price performance of PDEX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

PDEX long term performance overview.The bars show the price performance of PDEX in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of PDEX is 39.52 USD. In the past month the price decreased by -2.23%. In the past year, price increased by 23.5%.

PRO-DEX INC / PDEX Daily stock chart

PDEX Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to PDEX. When comparing the yearly performance of all stocks, PDEX is one of the better performing stocks in the market, outperforming 78.59% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
PDEX Full Technical Analysis Report

PDEX Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to PDEX. While PDEX has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PDEX Full Fundamental Analysis Report

PDEX Financial Highlights

Over the last trailing twelve months PDEX reported a non-GAAP Earnings per Share(EPS) of 3.24. The EPS increased by 61.19% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.94%
ROA 17.41%
ROE 26.96%
Debt/Equity 0.21
Chartmill High Growth Momentum
EPS Q2Q%8.2%
Sales Q2Q%11.12%
EPS 1Y (TTM)61.19%
Revenue 1Y (TTM)23.68%
PDEX financials

PDEX Forecast & Estimates

7 analysts have analysed PDEX and the average price target is 57.12 USD. This implies a price increase of 44.53% is expected in the next year compared to the current price of 39.52.

For the next year, analysts expect an EPS growth of -4.43% and a revenue growth 4.48% for PDEX


Analysts
Analysts82.86
Price Target57.12 (44.53%)
EPS Next Y-4.43%
Revenue Next Year4.48%
PDEX Analyst EstimatesPDEX Analyst Ratings

PDEX Ownership

Ownership
Inst Owners31.88%
Ins Owners36.03%
Short Float %12.12%
Short Ratio8.67
PDEX Ownership

PDEX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.54195.119B
ISRG INTUITIVE SURGICAL INC49.31179.003B
SYK STRYKER CORP25.15145.408B
BSX BOSTON SCIENTIFIC CORP21.29110.604B
BDX BECTON DICKINSON AND CO11.7752.82B
IDXX IDEXX LABORATORIES INC42.950.758B
EW EDWARDS LIFESCIENCES CORP26.8346.296B
GEHC GE HEALTHCARE TECHNOLOGY16.7738.388B
RMD RESMED INC21.137.749B
DXCM DEXCOM INC28.9428.503B

About PDEX

Company Profile

PDEX logo image Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 181 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).

Company Info

PRO-DEX INC

2361 McGaw Ave

Irvine CALIFORNIA 92614 US

CEO: Richard L. Van Kirk

Employees: 147

PDEX Company Website

PDEX Investor Relations

Phone: 19497693200

PRO-DEX INC / PDEX FAQ

Can you describe the business of PRO-DEX INC?

Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 181 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).


What is the current price of PDEX stock?

The current stock price of PDEX is 39.52 USD. The price increased by 1.33% in the last trading session.


What is the dividend status of PRO-DEX INC?

PDEX does not pay a dividend.


What is the ChartMill technical and fundamental rating of PDEX stock?

PDEX has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What sector and industry does PRO-DEX INC belong to?

PRO-DEX INC (PDEX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the market capitalization of PDEX stock?

PRO-DEX INC (PDEX) has a market capitalization of 126.86M USD. This makes PDEX a Micro Cap stock.